艾迪药业：公司股权激励计划的考核指标系基于公司长期战略目标与可持续发展能力综合设定

Core Viewpoint - The company emphasizes its stock incentive plan is designed to align with long-term strategic goals and sustainable development capabilities, focusing on net profit and revenue from HIV innovative drugs as core assessment targets [1] Group 1: Stock Incentive Plan - The stock incentive plan aims to enhance the motivation and innovation capabilities of core employees, promoting their growth alongside the company [1] - The plan is a key measure to implement the company's core strategy, directly linking operational effectiveness and performance in the innovative drug market [1] - The company acknowledges the capital market's expectations regarding the stock incentive plan and is committed to achieving performance targets through solid operational actions [1]